Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inborn Errors of Metabolism Disorders”

3,142 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,142 results

Not applicableLooking for participantsNCT00359684
What this trial is testing

Use of Cysteamine in the Treatment of Cystinosis

Who this might be right for
Cystinosis
National Human Genome Research Institute (NHGRI) 330
Not applicableUnknownNCT01898325
What this trial is testing

Assessment Of Liver and Spleen Fibrosis in Patients With Gaucher Disease Using Fibroscan

Who this might be right for
Fibrosis
Rambam Health Care Campus 40
Not applicableActive Not RecruitingNCT05526664
What this trial is testing

Omics Gaucher Study: Multiomic Approach

Who this might be right for
Gaucher Disease
CENTOGENE GmbH Rostock 25
Not applicableWithdrawnNCT01650909
What this trial is testing

The Effects of Sapropterin Dihydrochloride Supplementation on in Vivo Redox Status in Patients With Classical PKU

Who this might be right for
Classical Phenylketonuria(PKU)
Stanford University
Testing effectiveness (Phase 2)Study completedNCT03516487
What this trial is testing

Safety and Tolerability of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With Phenylketonuria

Who this might be right for
PhenylketonuriaHealthy
Synlogic 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07173933
What this trial is testing

Phase I/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of GC310 Injection in Patients With Wilson's Disease (WD)

Who this might be right for
Wilson Disease
GeneCradle Inc 15
Early research (Phase 1)Study completedNCT02262338
What this trial is testing

Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome

Who this might be right for
Mucopolysaccharidosis II
ArmaGen, Inc 6
Early research (Phase 1)Study completedNCT02536911
What this trial is testing

The Effects of Hepatic Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate

Who this might be right for
Gaucher Disease
Genzyme, a Sanofi Company 24
Testing effectiveness (Phase 2)Study completedNCT03350451
What this trial is testing

An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1

Who this might be right for
PH1Primary HyperoxaluriaRNAi Therapeutic+2 more
Alnylam Pharmaceuticals 20
Not applicableStudy completedNCT00531037
What this trial is testing

Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers

Who this might be right for
Patients Implanted With a Pacemaker
LivaNova 1,440
Not applicableLooking for participantsNCT06933212
What this trial is testing

Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy.

Who this might be right for
Cerebral Amyloid AngiopathyCAA - Cerebral Amyloid Angiopathy
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 86
Not applicableStudy completedNCT03432871
What this trial is testing

Nicotinamide Riboside and Mitochondrial Biogenesis

Who this might be right for
Mitochondrial DiseasesMitochondrial MyopathiesProgressive External Ophthalmoplegia+4 more
Cambridge University Hospitals NHS Foundation Trust 13
Not applicableStudy completedNCT00728364
What this trial is testing

Anderson-Fabry Disease in Chronic Kidney Disease Patients Not on Renal Replacement Therapy

Who this might be right for
Focus of Study: Prevalence of Fabry Disease in CKD Population
Klinikum Wels-Grieskirchen 4,353
Not applicableStudy completedNCT03292887
What this trial is testing

Hunter Outcome Survey (HOS)

Who this might be right for
Hunter Syndrome
Shire 1,443
Testing effectiveness (Phase 2)Study completedNCT01126814
What this trial is testing

Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia

Who this might be right for
Leukemia
University Health Network, Toronto 35
Not applicableStudy completedNCT06762509
What this trial is testing

The Clinical Study of Botulinum Toxin Type A Injection in the Treatment of Wilson Disease

Who this might be right for
Wilson Disease
The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine 60
Testing effectiveness (Phase 2)Study completedNCT00879034
What this trial is testing

Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

Who this might be right for
ProgeriaHutchinson-Gilford Syndrome
Boston Children's Hospital 5
Testing effectiveness (Phase 2)Looking for participantsNCT05994534
What this trial is testing

PK and PD Study of NPI-001 and Cysteamine Bitartrate

Who this might be right for
Cystinosis
Nacuity Pharmaceuticals, Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT04941599
What this trial is testing

2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)

Who this might be right for
Familial Hypercholesterolemia
Vanderbilt University Medical Center 72
Not applicableStudy completedNCT01625663
What this trial is testing

Heart and Muscle Metabolism in Barth Syndrome

Who this might be right for
Barth Syndrome
Duke University 64
Load More Results